Denbaars Steven 4
4 · Aeluma, Inc. · Filed May 21, 2026
Research Summary
AI-generated summary of this filing
Aeluma (ALMU) Director Steven Denbaars Sells 25,000 Shares
What Happened
Steven Denbaars, a director of Aeluma, sold a total of 25,000 shares in transactions on May 19–20, 2026, receiving aggregate proceeds of approximately $505,631. The sales reported were: 7,415 shares at a weighted average $19.56 ($145,026), 5,085 shares at $20.61 ($104,807), 11,558 shares at $20.40 ($235,734), and 942 shares at $21.30 ($20,064). These were sales (not purchases) and therefore are typically considered routine dispositions rather than a direct bullish signal.
Key Details
- Transaction dates: May 19 and May 20, 2026. Filing date: May 21, 2026 (appears timely).
- Reported weighted-average prices and reported price ranges per footnotes:
- 7,415 shares @ $19.56 (sales ranged $19.02–$20.01).
- 5,085 shares @ $20.61 (sales ranged $20.0244–$20.9963).
- 11,558 shares @ $20.40 (sales ranged $19.89–$20.8895).
- 942 shares @ $21.30 (sales ranged $20.907–$21.63).
- Proceeds: ~ $505,631 total.
- Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted November 20, 2025.
- The filing notes restricted stock unit vesting schedule for other awards (1/12 on 12/31/25; quarterly and other vesting through 11/30/26).
- Shares owned after the transactions are not specified in the provided excerpt.
Context
Sales executed under a pre-established 10b5‑1 plan are common for insiders to systematically dispose of shares and are generally treated as routine. Such dispositions do not necessarily reflect the insider’s current view of the company’s prospects. Retail investors should consider these trades as one data point and review Aeluma’s broader fundamentals and disclosures before drawing investment conclusions.
Insider Transaction Report
- Sale
Common Stock
[F1][F2][F3]2026-05-19$19.56/sh−7,415$145,026→ 387,794 total - Sale
Common Stock
[F1][F4]2026-05-19$20.61/sh−5,085$104,807→ 382,709 total - Sale
Common Stock
[F1][F5]2026-05-20$20.40/sh−11,558$235,734→ 371,151 total - Sale
Common Stock
[F1][F6]2026-05-20$21.30/sh−942$20,064→ 370,209 total
Footnotes (6)
- [F1]Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025.
- [F2]Restricted stock units scheduled to vest with respect to approximately 1/12 of the shares on December 31, 2025, 1/4 of the shares on March 31, June 30, and September 30, 2026, and 1/6 of the shares on November 30, 2026.
- [F3]The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $19.02 to $20.01, inclusive.
- [F4]The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $20.0244 to $20.9963, inclusive.
- [F5]The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $19.89 to $20.8895, inclusive.
- [F6]The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $20.907 to $21.63, inclusive.